Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus

Hormone and Metabolic Research

Volumn 36, Issue 4, 2004, Pages 238-242

  Ezenwaka, C E ^a   Kalloo, R ^a   Uhlig, M ^b   Eckel, J ^b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Adiponectin; Cardiovascular disease; Metabolism; Offspring; Type 2 diabetes

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANTHROPOMETRY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FAMILY HEALTH; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; RISK FACTORS; TRIGLYCERIDES; TRINIDAD AND TOBAGO;

EID: 2442480577     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814454     Document Type: Article

References (31)

1. Barnett AH, Effo C, Leslie RD, Pyke DA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87-93
2. Newman B, Sleby JV, King MC, Slemenda C, Fabsitz P, Friedman CD. Concordance for type 2 (NIDDM) diabetes in male twins. Diabetologia 1987; 30: 763-768
3. Haffner SM, Stern MP, Hazuda HP, Mitchel BD, Patterson JK. Increased insulin concentration in non-diabetic offspring of diabetic parents. N Engl J Med 1988; 319: 1297-1301
4. Warram JH, Blaise CM, Andrez S, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinaemia precede the development of type 11 diabetes in the offspring of diabetic parents. Ann Int Med 1990; 113: 909-915
5. Eriksson JE, Franssila KA, Ekstrand CS, Widen W, Schalin C. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl. J Med 1989; 320: 337-343
6. Osei K. Increased basal glucose production and utilisation in non-diabetic first-degree relatives of patients with NIDDM. Diabetes 1990; 39: 597-601
7. Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type 11 diabetes: implications for syndrome X. Diabetes Care 1997; 20: 745-752
8. Ezenwaka CE, Akanji AO, Osei K, Adejuwon CA, O'Dorisio TM, Cotrell DA, Akinlade KS. Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1993; 20: 175-181
9. Snethalatha c, Ramachandran A, Satyavani K, Latha E, Viswanathan V. Study of genetic prediabetic South Indian subjects: importance of hyperinsulinemia and B-cell dysfunction. Diabetes Care 1998; 21: 76-79
10. Ezenwaka CE, Davis G, Offiah NV. Insulin secretion in glucose-tolerant offspring of type 2 diabetes patients in Trinidad, West Indies. Southern Med J 2001; 94: 223-228
11. Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 1995; 18: 1020-1022
12. Ezenwaka CE, Davis G, Offiah NV. Evaluation of features of syndrome X in offspring of Caribbean patients with type 2 diabetes. Scand J Clin Lab Invest 2001; 61: 19-26
13. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003; 26: 2015-2020
14. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935
15. Zietz B, Herfarth H, Paul G, Ehling A, Muller-Ladner U, Scholmerich J, Schaffler A. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett. 2003; 545: 103-104
16. Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003; 52: 1182-1186
17. Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 2003; 25: 31-135
18. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88: 3236-3240
19. Heilbronn LK, Smith SR, Ravussin E. The insulin-sensitizing role of the fat derived hormone adiponectin. Curr Pharm Des. 2003; 9: 1411-1418
20. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003; 148: 293-300
21. Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res. 2002; 34: 469-474
22. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl. 5): S7-S85
23. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
25. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982; 23: 313-319
26. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126-1133
27. Ezenwaka CE. Prospective study of offspring of Caribbean patients with type 2 diabetes: results of a 1-year follow-up study. Canadian J Diabetes 2003; 27(3): 248-255
28. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipocyte specific protein, adiponectin in obesity. Biochem Biophys Res Commun 1999; 257: 79-83
29. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599
30. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecule: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476
31. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749